Suppr超能文献

兔四环素诱导性胸膜损伤中纤维蛋白溶解疗法期间粘连溶解的时间进程。

The time course of resolution of adhesions during fibrinolytic therapy in tetracycline-induced pleural injury in rabbits.

作者信息

Komissarov Andrey A, Florova Galina, Azghani Ali O, Buchanan Ann, Bradley William M, Schaefer Chris, Koenig Kathleen, Idell Steven

机构信息

The Department of Cellular and Molecular Biology and the Texas Lung Injury Institute, The University of Texas Health Science Center at Tyler (UTHSCT), Tyler, Texas;

The Department of Biology at the University of Texas at Tyler, Tyler, Texas;

出版信息

Am J Physiol Lung Cell Mol Physiol. 2015 Sep 15;309(6):L562-72. doi: 10.1152/ajplung.00136.2015. Epub 2015 Jul 10.

Abstract

The time required for the effective clearance of pleural adhesions/organization after intrapleural fibrinolytic therapy (IPFT) is unknown. Chest ultrasonography and computed tomography (CT) were used to assess the efficacy of IPFT in a rabbit model of tetracycline-induced pleural injury, treated with single-chain (sc) urokinase plasminogen activators (scuPAs) or tissue PAs (sctPA). IPFT with sctPA (0.145 mg/kg; n = 10) and scuPA (0.5 mg/kg; n = 12) was monitored by serial ultrasonography alone (n = 12) or alongside CT scanning (n = 10). IPFT efficacy was assessed with gross lung injury scores (GLIS) and ultrasonography scores (USS). Pleural fluids withdrawn at 0-240 min and 24 h after IPFT were assayed for PA and fibrinolytic activities, α-macroglobulin/fibrinolysin complexes, and active PA inhibitor 1 (PAI-1). scuPA and sctPA generated comparable steady-state fibrinolytic activities by 20 min. PA activity in the scuPA group decreased slower than the sctPA group (kobs = 0.016 and 0.042 min(-1)). Significant amounts of bioactive uPA/α-macroglobulin (but not tPA; P < 0.05) complexes accumulated at 0-40 min after IPFT. Despite the differences in intrapleural processing, IPFT with either fibrinolysin was effective (GLIS ≤ 10) in animals imaged with ultrasonography only. USS correlated well with postmortem GLIS (r(2) = 0.85) and confirmed relatively slow intrapleural fibrinolysis after IPFT, which coincided with effective clearance of adhesions/organization at 4-8 h. CT scanning was associated with less effective (GLIS > 10) IPFT and higher levels of active PAI-1 at 24 h following therapy. We concluded that intrapleural fibrinolysis in tetracycline-induced pleural injury in rabbits is relatively slow (4-8 h). In CT-scanned animals, elevated PAI-1 activity (possibly radiation induced) reduced the efficacy of IPFT, buttressing the major impact of active PAI-1 on IPFT outcomes.

摘要

胸膜内纤维蛋白溶解疗法(IPFT)后有效清除胸膜粘连/机化所需的时间尚不清楚。在四环素诱导的胸膜损伤兔模型中,使用胸部超声和计算机断层扫描(CT)来评估IPFT的疗效,该模型用单链(sc)尿激酶型纤溶酶原激活剂(scuPAs)或组织型纤溶酶原激活剂(sctPA)进行治疗。单独通过连续超声检查(n = 12)或联合CT扫描(n = 10)监测sctPA(0.145 mg/kg;n = 10)和scuPA(0.5 mg/kg;n = 12)的IPFT。用总肺损伤评分(GLIS)和超声评分(USS)评估IPFT疗效。在IPFT后0 - 240分钟和24小时抽取的胸水检测纤溶酶原激活剂(PA)和纤溶活性、α-巨球蛋白/纤溶酶复合物以及活性PA抑制剂1(PAI-1)。scuPA和sctPA在20分钟时产生了相当的稳态纤溶活性。scuPA组的PA活性下降比sctPA组慢(观测速率常数分别为0.016和0.042分钟⁻¹)。IPFT后0 - 40分钟有大量生物活性尿激酶型纤溶酶原激活剂/α-巨球蛋白(而非组织型纤溶酶原激活剂;P < 0.05)复合物积累。尽管胸膜内处理存在差异,但仅用超声成像的动物中,使用任何一种纤溶酶进行IPFT都是有效的(GLIS≤10)。USS与死后GLIS相关性良好(r² = 0.85),并证实IPFT后胸膜内纤溶相对缓慢,这与4 - 8小时粘连/机化的有效清除相吻合。CT扫描与疗效较差(GLIS > 10)的IPFT相关,且治疗后24小时活性PAI-1水平较高。我们得出结论,兔四环素诱导的胸膜损伤中胸膜内纤溶相对缓慢(4 - 8小时)。在CT扫描的动物中,PAI-1活性升高(可能是辐射诱导)降低了IPFT的疗效,这支持了活性PAI-1对IPFT结果的主要影响。

相似文献

1
The time course of resolution of adhesions during fibrinolytic therapy in tetracycline-induced pleural injury in rabbits.
Am J Physiol Lung Cell Mol Physiol. 2015 Sep 15;309(6):L562-72. doi: 10.1152/ajplung.00136.2015. Epub 2015 Jul 10.
2
Active α-macroglobulin is a reservoir for urokinase after fibrinolytic therapy in rabbits with tetracycline-induced pleural injury and in human pleural fluids.
Am J Physiol Lung Cell Mol Physiol. 2013 Nov 15;305(10):L682-92. doi: 10.1152/ajplung.00102.2013. Epub 2013 Aug 30.
4
Targeting plasminogen activator inhibitor-1 in tetracycline-induced pleural injury in rabbits.
Am J Physiol Lung Cell Mol Physiol. 2018 Jan 1;314(1):L54-L68. doi: 10.1152/ajplung.00579.2016. Epub 2017 Aug 31.
5
Dose dependency of outcomes of intrapleural fibrinolytic therapy in new rabbit empyema models.
Am J Physiol Lung Cell Mol Physiol. 2016 Aug 1;311(2):L389-99. doi: 10.1152/ajplung.00171.2016. Epub 2016 Jun 24.
6
Regulation of intrapleural fibrinolysis by urokinase-alpha-macroglobulin complexes in tetracycline-induced pleural injury in rabbits.
Am J Physiol Lung Cell Mol Physiol. 2009 Oct;297(4):L568-77. doi: 10.1152/ajplung.00066.2009. Epub 2009 Aug 7.
7
Intrapleural Fibrinolytic Interventions for Retained Hemothoraces in Rabbits.
Int J Mol Sci. 2024 Aug 12;25(16):8778. doi: 10.3390/ijms25168778.
9
Intrapleural adenoviral delivery of human plasminogen activator inhibitor-1 exacerbates tetracycline-induced pleural injury in rabbits.
Am J Respir Cell Mol Biol. 2013 Jan;48(1):44-52. doi: 10.1165/rcmb.2012-0183OC. Epub 2012 Sep 20.
10
Intrapleural activation, processing, efficacy, and duration of protection of single-chain urokinase in evolving tetracycline-induced pleural injury in rabbits.
Am J Physiol Lung Cell Mol Physiol. 2007 Jan;292(1):L25-32. doi: 10.1152/ajplung.00118.2006. Epub 2006 Sep 15.

引用本文的文献

4
Imaging Biomarkers in Animal Models of Drug-Induced Lung Injury: A Systematic Review.
J Clin Med. 2020 Dec 30;10(1):107. doi: 10.3390/jcm10010107.
6
Intrapleural Fibrinolytic Therapy for Empyema and Pleural Loculation: Knowns and Unknowns.
Ann Am Thorac Soc. 2018 May;15(5):515-517. doi: 10.1513/AnnalsATS.201711-848PS.
7
Fibrin turnover and pleural organization: bench to bedside.
Am J Physiol Lung Cell Mol Physiol. 2018 May 1;314(5):L757-L768. doi: 10.1152/ajplung.00501.2017. Epub 2018 Jan 18.
8
Targeting plasminogen activator inhibitor-1 in tetracycline-induced pleural injury in rabbits.
Am J Physiol Lung Cell Mol Physiol. 2018 Jan 1;314(1):L54-L68. doi: 10.1152/ajplung.00579.2016. Epub 2017 Aug 31.
9
Dose dependency of outcomes of intrapleural fibrinolytic therapy in new rabbit empyema models.
Am J Physiol Lung Cell Mol Physiol. 2016 Aug 1;311(2):L389-99. doi: 10.1152/ajplung.00171.2016. Epub 2016 Jun 24.

本文引用的文献

2
Urokinase versus VATS for treatment of empyema: a randomized multicenter clinical trial.
Pediatrics. 2014 Nov;134(5):e1301-7. doi: 10.1542/peds.2013-3935.
4
Fibrinolytics in parapneumonic effusions/empyemas.
Chest. 2014 Sep;146(3):e103-e104. doi: 10.1378/chest.14-0706.
7
In vivo changes in plasma coenzyme Q10, carotenoid, tocopherol, and retinol levels in children after computer tomography.
Arch Biochem Biophys. 2014 Apr 1;547:37-43. doi: 10.1016/j.abb.2014.02.007. Epub 2014 Feb 25.
9
Active α-macroglobulin is a reservoir for urokinase after fibrinolytic therapy in rabbits with tetracycline-induced pleural injury and in human pleural fluids.
Am J Physiol Lung Cell Mol Physiol. 2013 Nov 15;305(10):L682-92. doi: 10.1152/ajplung.00102.2013. Epub 2013 Aug 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验